Immunobiological peculiarities of cholesteatoma in children: Quantification of epithelial proliferation by MIB 1

Laryngoscope

Volumn 106, Issue 7, 1996, Pages 865-868

  Bujía, Jesús ^a,c   Holly, Anja ^a   Antolí Candela, Francisco ^b   Tapia, Mario Guzman ^b   Kastenbauer, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Instituto ORL Antoli Candela   (Spain)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGE; ARTICLE; AUDITORY CANAL; CELL PROLIFERATION; CHILD; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOBIOLOGY; KERATINOCYTE; PRIORITY JOURNAL; SKIN;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; CHILD; CHOLESTEATOMA, MIDDLE EAR; EPITHELIUM; HUMANS; KERATINOCYTES; KI-67 ANTIGEN; NUCLEAR PROTEINS;

EID: 0029956959     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199607000-00015     Document Type: Article

References (24)

1. Bujia J, Schilling V, Holly A, et al. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh). 1993;113:364-368.
2. Bujia J, Holly A, Schilling V, et al. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. LARYNGOSCOPE. 1993;103:326-329.
3. Schulz P, Bujia J, Holly A. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor-alpha. Am J Otolaryngol. 1993;14:82-87.
4. Schilling V, Negri B, Bujia J, et al. Possible role of interleukin-1 alpha and interleukin-1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol. 1991;12:249-253.
5. Bujia J, Kim C, Ostos P, et al. Role of Interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatoma. Eur Arch Otolaryngol. 1995;23:345-348.
6. Palva A, Karma P, Kärjä J. Cholesteatoma in children. Arch Otolaryngol. 1977;103:74-77.
7. Gerdes J, Schwab U, Lemke H. et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983;31:13-20.
8. Gerdes J, Lemke J, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
9. Walker RA, Camplejohn RS. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer. 1988;57:281-284.
10. Van Erp Pej, Groenendal H, Bauer FW, et al. Growth fraction in epidermal skin disorders determined by the monoclonal antibody ki67. J Invest Dermatol. 1987;89:313.
11. Sittinger M, Bujia J, Burmester G. Inexpensive computer analysis of cell and tissue staining. In Vitro Cell Dev Biol. 1994; 30A:559-561.
12. Sheehy JL: Management of cholesteatoma in children. Adv Otorhinolaryngol. 1978;23:58-64.
13. Laskiewicz B, Chalstrey S, Gatland DJ, et al. Congenital cholesteatoma. J Laryngol Otol. 1991;105:995-998.
14. Sanna M, Zini C, Scandellari R, et al. Residual and recurrent cholesteatoma in closed tympanoplasty. Am J Otol. 1984;5: 277-282.
15. Rosenfeld RM, Moura RL, Bluestone CD. Predictors of residual-recurrent cholesteatoma in children. Arch Otolaryngol Head Neck Surg. 1992;118:384-439.
16. Bujia J, Holly A, Sudhoff H, et al. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. ORL J Otorhinolaryngol Relat Spec. 1995;24:342-348.
17. Sudhoff H, Bujia J, Fisseler-Eckhoff A, et al. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. LARYNGOSCOPE. 1995;105: 1227-1231.
18. Camplejohn RS, Aherne WA. In vitro labelling of childhood cancers with tritiated thymidine. Br J Cancer. 1974;29:487-489.
19. Hoshina T, Wilson CB. Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer. 1979;44:956-962.
20. Hoshino H, Nagashima T, Murovic JA. In Situ cell kinetics studies of human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg. 1986;64:453-459.
21. Nagashima T, Dearnond SJ, Murovic J, et al. Immunocytochemical demonstration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl). 1985;67:155-159.
22. Ando M, Kawashima T, Kobayashi H, et al. Proliferating cells in the normal and psoriatic epidermis detected by Ki67 monoclonal antibody. J Invest Dermatol. 1989;92:395.
23. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol. 1986;10:611-617.
24. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of HuKi67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-363.